Year All202420232022 October 10, 2024 CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering July 22, 2024 Ceribell Announces Publication of Study Demonstrating Significant Reduction in Length of ICU Stays and Better Patient Outcomes with Ceribell Point-of-Care EEG Compared to Conventional EEG April 2, 2024 Ceribell Appoints Sean Manni as Senior Vice President of Sales January 4, 2024 Ceribell to Present at the 42nd Annual J.P. Morgan Healthcare Conference October 30, 2023 Ceribell Launches ClarityPro™ AI, Expanding Access to Critical Diagnosis of Electrographic Status Epilepticus October 2, 2023 Ceribell Appoints Joshua Copp as Chief Operating Officer August 31, 2023 Ceribell Appoints Louisa Daniels as General Counsel August 3, 2023 Ceribell Receives FDA 510(k) Clearance and CMS NTAP Reimbursement for New ClarityPro™ Software with Electrographic Status Epilepticus Diagnostic Indication March 2, 2023 Ceribell Named to Fast Company's 2023 List of the World's Most Innovative Companies January 5, 2023 Ceribell to Present at the 41st Annual J.P. Morgan Healthcare Conference
July 22, 2024 Ceribell Announces Publication of Study Demonstrating Significant Reduction in Length of ICU Stays and Better Patient Outcomes with Ceribell Point-of-Care EEG Compared to Conventional EEG
October 30, 2023 Ceribell Launches ClarityPro™ AI, Expanding Access to Critical Diagnosis of Electrographic Status Epilepticus
August 3, 2023 Ceribell Receives FDA 510(k) Clearance and CMS NTAP Reimbursement for New ClarityPro™ Software with Electrographic Status Epilepticus Diagnostic Indication